These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16579864)

  • 21. The costs and consequences of three policy options for reducing heroin dependency.
    Moore TJ; Ritter A; Caulkins JP
    Drug Alcohol Rev; 2007 Jul; 26(4):369-78. PubMed ID: 17564872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heroin-assisted treatment in Switzerland: a case study in policy change.
    Uchtenhagen A
    Addiction; 2010 Jan; 105(1):29-37. PubMed ID: 19922519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Australian heroin seizures and the causes of the 2001 heroin shortage.
    Jiggens J
    Int J Drug Policy; 2008 Aug; 19(4):273-8. PubMed ID: 17920258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What caused the recent reduction in heroin supply in Australia?
    Wodak A
    Int J Drug Policy; 2008 Aug; 19(4):279-86. PubMed ID: 18554895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of a reduction in drug supply on demand for and compliance with treatment for drug dependence.
    Degenhardt L; Conroy E; Day C; Gilmour S; Hall W
    Drug Alcohol Depend; 2005 Aug; 79(2):129-35. PubMed ID: 16002022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of law enforcement activity on a heroin market.
    Weatherburn D; Lind B
    Addiction; 1997 May; 92(5):557-69; discussion 611-3. PubMed ID: 9219378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Illicit drugs and the media: models of media effects for use in drug policy research.
    Lancaster K; Hughes CE; Spicer B; Matthew-Simmons F; Dillon P
    Drug Alcohol Rev; 2011 Jul; 30(4):397-402. PubMed ID: 21355898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estimating the economic value of British Columbia's domestic cannabis market: implications for provincial cannabis policy.
    Werb D; Nosyk B; Kerr T; Fischer B; Montaner J; Wood E
    Int J Drug Policy; 2012 Nov; 23(6):436-41. PubMed ID: 23085258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Learning from uncommon events: comment on Degenhardt et al. 2005.
    Jaffe JH
    Addiction; 2005 Jul; 100(7):921-2; discussion 930-2. PubMed ID: 15955000
    [No Abstract]   [Full Text] [Related]  

  • 30. Interrupted time-series analysis: studying trends in neurosurgery.
    Wong RH; Smieliauskas F; Pan IW; Lam SK
    Neurosurg Focus; 2015 Dec; 39(6):E6. PubMed ID: 26621420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Issues in applied statistics for public health bioterrorism surveillance using multiple data streams: research needs.
    Rolka H; Burkom H; Cooper GF; Kulldorff M; Madigan D; Wong WK
    Stat Med; 2007 Apr; 26(8):1834-56. PubMed ID: 17221940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Documenting the heroin shortage in New South Wales.
    Day C; Degenhardt L; Hall W
    Drug Alcohol Rev; 2006 Jul; 25(4):297-305. PubMed ID: 16854654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Capitalising upon political opportunities to reform drug policy: a case study into the development of the Australian "Tough on Drugs-Illicit Drug Diversion Initiative".
    Hughes CE
    Int J Drug Policy; 2009 Sep; 20(5):431-7. PubMed ID: 19162458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The size and mix of government spending on illicit drug policy in Australia.
    Moore TJ
    Drug Alcohol Rev; 2008 Jul; 27(4):404-13. PubMed ID: 18584391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Part 4. Interaction between air pollution and respiratory viruses: time-series study of daily mortality and hospital admissions in Hong Kong.
    Wong CM; Thach TQ; Chau PY; Chan EK; Chung RY; Ou CQ; Yang L; Peiris JS; Thomas GN; Lam TH; Wong TW; Hedley AJ;
    Res Rep Health Eff Inst; 2010 Nov; (154):283-362. PubMed ID: 21446214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of illicit drug market changes on health agency operations in Sydney, Australia.
    Gibson A; Day C; Degenhardt L
    J Subst Abuse Treat; 2005 Jan; 28(1):35-40. PubMed ID: 15723730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methods for comparing drug policies--the utility of composite drug harm indexes.
    Ritter A
    Int J Drug Policy; 2009 Nov; 20(6):475-9. PubMed ID: 19356915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Australian heroin seizures and the causes of the 2001 heroin shortage.
    Degenhardt L; Hall W
    Int J Drug Policy; 2008 Aug; 19(4):293-4; discussion 295-6. PubMed ID: 18485688
    [No Abstract]   [Full Text] [Related]  

  • 39. Effective drug policy: a new approach demonstrated in the Drug Policy Modelling Program.
    Ritter A; Bammer G; Hamilton M; Mazerolle L;
    Drug Alcohol Rev; 2007 May; 26(3):265-71. PubMed ID: 17454015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Civil society-a leader in HIV prevention and tobacco control.
    Malinowska-Sempruch K; Bonnell R; Hoover J
    Drug Alcohol Rev; 2006 Nov; 25(6):625-32. PubMed ID: 17132578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.